Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis

Escient Pharmaceuticals, Inc · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
atopic-dermatitis
atopic dermatitis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 845579
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.